Bank of New York Mellon’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $319K | Sell |
94,603
-745
| -0.8% | -$2.51K | ﹤0.01% | 3744 |
|
|
2025
Q1 | $368K | Hold |
95,348
| – | – | ﹤0.01% | 3589 |
|
|
2024
Q4 | $588K | Sell |
95,348
-3,777
| -4% | -$23.3K | ﹤0.01% | 3417 |
|
|
2024
Q3 | $533K | Sell |
99,125
-18,985
| -16% | -$102K | ﹤0.01% | 3478 |
|
|
2024
Q2 | $396K | Buy |
118,110
+2,868
| +2% | +$9.61K | ﹤0.01% | 3687 |
|
|
2024
Q1 | $464K | Sell |
115,242
-5,550
| -5% | -$22.4K | ﹤0.01% | 3560 |
|
|
2023
Q4 | $320K | Hold |
120,792
| – | – | ﹤0.01% | 3765 |
|
|
2023
Q3 | $285K | Sell |
120,792
-1,873
| -2% | -$4.42K | ﹤0.01% | 3815 |
|
|
2023
Q2 | $773K | Sell |
122,665
-1,388
| -1% | -$8.74K | ﹤0.01% | 3353 |
|
|
2023
Q1 | $716K | Sell |
124,053
-2,431
| -2% | -$14K | ﹤0.01% | 3294 |
|
|
2022
Q4 | $1.3M | Buy |
126,484
+1,277
| +1% | +$13.1K | ﹤0.01% | 3069 |
|
|
2022
Q3 | $2.09M | Buy |
125,207
+22,823
| +22% | +$382K | ﹤0.01% | 2817 |
|
|
2022
Q2 | $1.43M | Buy |
102,384
+12,428
| +14% | +$174K | ﹤0.01% | 3017 |
|
|
2022
Q1 | $1.45M | Buy |
89,956
+22,848
| +34% | +$369K | ﹤0.01% | 3100 |
|
|
2021
Q4 | $1.44M | Buy |
67,108
+30,632
| +84% | +$656K | ﹤0.01% | 3174 |
|
|
2021
Q3 | $536K | Buy |
36,476
+2,979
| +9% | +$43.8K | ﹤0.01% | 3769 |
|
|
2021
Q2 | $666K | Buy |
+33,497
| New | +$666K | ﹤0.01% | 3631 |
|